Ionis Pharmaceuticals, Inc. Earnings

Ionis Pharmaceuticals, Inc.’s revenue jumped 10.14% since last year same period to $131.61Mn in the Q1 2025. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated -41.91% fall in its revenue since last 3-months.

Ionis Pharmaceuticals, Inc.’s net profit fell -2.9% since last year same period to $-146.94Mn in the Q1 2025. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated -40.81% fall in its net profits since last 3-months.

Ionis Pharmaceuticals, Inc.’s net profit margin jumped 6.58% since last year same period to -111.64% in the Q1 2025. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated -142.42% fall in its net profit margins since last 3-months.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.94 - a -276.75% fall from last quarter’s estimates.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -0.94.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Ionis Pharmaceuticals, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.